Stalz Charles Vilbrun
Stalz Charles Vilbrun publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Pneumonia and Respiratory Infections and Mycobacterium research and diagnosis.
- World rank
- #2,797,376 of 7,710,434 ranked researchers
- Rank in Haiti
- #16 of 57
- Works
- 37
- Citations
- 1.2k
- Citations per work
- 33.1
What does Stalz Charles Vilbrun research?
Stalz Charles Vilbrun's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2876.1%
- Medicine2876.1%
- Everything else615.7%
- Life Sciences38.2%
- 1Infectious Diseases43% of their works
- 2Epidemiology26% of their works
- 3Surgery7% of their works
- 4Molecular Biology5% of their works
- 5Molecular Medicine2% of their works
- 6Genetics2% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Pneumonia and Respiratory Infections
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS drug development and treatment
- Infectious Diseases and Tuberculosis
- Gut microbiota and health
- Clostridium difficile and Clostridium perfringens research
Which keywords describe Stalz Charles Vilbrun's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Drug Resistance, Mycobacterium tuberculosis, Tuberculosis, Clinical Practice Guidelines and Antiretroviral Therapy.
- Gut Microbiota
- Antibiotic-Associated Diarrhea
- Spinal Epidural Abscess
- Integrase Inhibitors
- Pneumocystis
- Mycobacterium avium
- Pneumococcal Conjugate Vaccine
- Antiretroviral Therapy
- Tuberculosis
- Drug Resistance
- Diagnosis
- Epidemiology
- Treatment
- Mycobacterium tuberculosis
- Clinical Practice Guidelines
- Community-Acquired Pneumonia
- HIV Infection
- Nontuberculous Mycobacteria
- Pneumonia
- Nucleoside Analogues
- Tuberculous Meningitis
- Fecal Microbiota Transplantation
- Microbial Communities
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Epidemiology615 topics
- Diagnosis463 topics
- Treatment463 topics
- Drug Resistance362 topics
- Mycobacterium tuberculosis311 topic
- Tuberculosis311 topic
- Clinical Practice Guidelines203 topics
- Antiretroviral Therapy163 topics
- Community-Acquired Pneumonia111 topic
- Pneumococcal Conjugate Vaccine111 topic
- HIV Infection102 topics
- Mycobacterium avium91 topic
- Nontuberculous Mycobacteria91 topic
- Pneumocystis61 topic
- Pneumonia61 topic
- Integrase Inhibitors51 topic
- Nucleoside Analogues51 topic
- Spinal Epidural Abscess51 topic
- Tuberculous Meningitis51 topic
- Antibiotic-Associated Diarrhea41 topic
- Fecal Microbiota Transplantation41 topic
- Gut Microbiota41 topic
- Microbial Communities41 topic
Where does Stalz Charles Vilbrun work?
Stalz Charles Vilbrun's main affiliation in the publication record is Gheskio Centers, Haiti.
How many publications and citations does Stalz Charles Vilbrun have?
OpenAlex counts 37 works and 1,224 citations for Stalz Charles Vilbrun, an h-index of 14, ranking #2,797,376 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stalz Charles Vilbrun. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.